| Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations D Omran, M Alboraie, RA Zayed, MN Wifi, M Naguib, M Eltabbakh, ... World journal of gastroenterology 24 (38), 4330, 2018 | 149 | 2018 |
| Sofosbuvir plus daclatasvir in treatment of chronic hepatitis C genotype 4 infection in a cohort of Egyptian patients: an experiment the size of Egyptian village OA Ahmed, E Safwat, MO Khalifa, AI Elshafie, MHA Fouad, MM Salama, ... International journal of hepatology 2018, 2018 | 96 | 2018 |
| Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C‐infected Egyptian cohort: a comparative analysis M El Kassas, AL Funk, M Salaheldin, Y Shimakawa, M Eltabbakh, K Jean, ... Journal of viral hepatitis 25 (6), 623-630, 2018 | 94 | 2018 |
| A significant upsurge of body mass index in patients with chronic hepatitis C successfully treated with direct-acting antiviral regimens M El Kassas, M Alboraie, M Naguib, H Omar, A El Tahan, I Moaz, ... The Turkish Journal of Gastroenterology 30 (8), 708, 2019 | 19 | 2019 |
| Egyptian liver library: an indexed database for liver disease evidence in Egypt M Alboraie, N Youssef, AF Sherief, S Afify, MN Wifi, D Omran, E Hafez, ... Arab Journal of Gastroenterology 20 (2), 109-113, 2019 | 19 | 2019 |
| Response to direct-acting antiviral agents is affected by manifestations of portal hypertension in patients with chronic hepatitis C infections MA Alboraie, MS Abdelhamid, MM Eltabbakh, IM Moaz, MF Abd Algaber, ... Journal of Advanced Research 16, 164-165, 2019 | | 2019 |
